Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Estrogen receptor expression in sporadic vestibular schwannomas.

Brown CM, Ahmad ZK, Ryan AF, Doherty JK.

Otol Neurotol. 2011 Jan;32(1):158-62. doi: 10.1097/MAO.0b013e3181feb92a.

2.

Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.

Patel AK, Alexander TH, Andalibi A, Ryan AF, Doherty JK.

Laryngoscope. 2008 Aug;118(8):1458-63. doi: 10.1097/MLG.0b013e318177e20b.

3.
4.

Age dependent phosphorylation and deregulation of p53 in human vestibular schwannomas.

Dayalan AH, Jothi M, Keshava R, Thomas R, Gope ML, Doddaballapur SK, Somanna S, Praharaj SS, Ashwathnarayanarao CB, Gope R.

Mol Carcinog. 2006 Jan;45(1):38-46.

PMID:
16299809
5.
6.

Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.

Kuske B, Naughton C, Moore K, Macleod KG, Miller WR, Clarke R, Langdon SP, Cameron DA.

Endocr Relat Cancer. 2006 Dec;13(4):1121-33.

7.

Over-expressed estrogen receptor-alpha up-regulates hTNF-alpha gene expression and down-regulates beta-catenin signaling activity to induce the apoptosis and inhibit proliferation of LoVo colon cancer cells.

Hsu HH, Cheng SF, Chen LM, Liu JY, Chu CH, Weng YJ, Li ZY, Lin CS, Lee SD, Kuo WW, Huang CY.

Mol Cell Biochem. 2006 Sep;289(1-2):101-9. Epub 2006 Apr 21.

PMID:
16628468
8.

Treatment of vestibular schwannoma cells with ErbB inhibitors.

Bush ML, Burns SS, Oblinger J, Davletova S, Chang LS, Welling DB, Jacob A.

Otol Neurotol. 2012 Feb;33(2):244-57. doi: 10.1097/MAO.0b013e31823e287f.

9.

Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.

Bian LG, Tirakotai W, Sun QF, Zhao WG, Shen JK, Luo QZ.

J Neurooncol. 2005 Jul;73(3):253-60.

PMID:
15980976
10.

Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells.

Dilwali S, Roberts D, Stankovic KM.

Cancer Biol Ther. 2015;16(1):170-5. doi: 10.4161/15384047.2014.972765.

11.

Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue.

Fasco MJ, Hurteau GJ, Spivack SD.

Mol Cell Endocrinol. 2002 Feb 25;188(1-2):125-40.

PMID:
11911952
12.

Estrogen receptor (ER) expression and function in the pregnant human myometrium: estradiol via ERα activates ERK1/2 signaling in term myometrium.

Welsh T, Johnson M, Yi L, Tan H, Rahman R, Merlino A, Zakar T, Mesiano S.

J Endocrinol. 2012 Feb;212(2):227-38. doi: 10.1530/JOE-11-0358. Epub 2011 Nov 8.

13.

Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.

Diensthuber M, Ilner T, Rodt T, Samii M, Brandis A, Lenarz T, Stöver T.

Otol Neurotol. 2007 Jun;28(4):559-65.

PMID:
17429338
14.

Altered structure and expression of RB1 gene and increased phosphorylation of pRb in human vestibular schwannomas.

Thomas R, Prabhu PD, Mathivanan J, Rohini, Sivakumar D, Jayakumar PN, Devi BI, Satish S, Sastry KV, Gope R.

Mol Cell Biochem. 2005 Mar;271(1-2):113-21.

PMID:
15881662
15.

Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors.

Shupnik MA, Pitt LK, Soh AY, Anderson A, Lopes MB, Laws ER Jr.

J Clin Endocrinol Metab. 1998 Nov;83(11):3965-72.

PMID:
9814476
16.

Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.

Yener U, Avsar T, Akgün E, Şeker A, Bayri Y, Kılıç T.

J Neurosurg. 2012 Oct;117(4):697-704. doi: 10.3171/2012.6.JNS112263. Epub 2012 Aug 17.

PMID:
22900848
17.

Simultaneous measurement of ERα, HER2, and phosphoERK1/2 in breast cancer cell lines by flow cytometry.

Bayraktar UD, Kim TK, Drews-Elger K, Benjamin C, El-Ashry D, Wieder E, Komanduri KV.

Breast Cancer Res Treat. 2011 Sep;129(2):623-8. doi: 10.1007/s10549-011-1586-z. Epub 2011 May 24.

PMID:
21607585
18.
19.

Phospho-serine-118 estrogen receptor-alpha detection in human breast tumors in vivo.

Murphy L, Cherlet T, Adeyinka A, Niu Y, Snell L, Watson P.

Clin Cancer Res. 2004 Feb 15;10(4):1354-9.

20.

Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer.

Yamashita H, Nishio M, Toyama T, Sugiura H, Kondo N, Kobayashi S, Fujii Y, Iwase H.

Endocr Relat Cancer. 2008 Sep;15(3):755-63. doi: 10.1677/ERC-08-0078. Epub 2008 Jun 12.

Supplemental Content

Support Center